Influenza A/H5N1 Vaccine

BIOLOGICAL4 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Influenza

Phase 1

A/H5N1in Adult - Aventis

CompletedNCT00115986

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2005-03-31End: 2006-02-28Updated: 2013-08-23

A/H5N1 Vaccine in Healthy Children Aged 2-9 Years

CompletedNCT00133536

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2006-01-31End: 2007-04-30Updated: 2010-08-27

Inactivated Influenza A/H5N1 Vaccine in the Elderly

CompletedNCT00230750

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2005-10-31End: 2007-01-31Updated: 2013-08-23

H5N1 Vaccination With and Without AS03: Systems Biology Analysis

CompletedNCT01573312

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2012-05-24End: 2014-01-02Updated: 2019-10-21

Related Papers

Metabolomic Signatures Differentiate Immune Responses in Avian Influenza Vaccine Recipients.

2024-09-013 citations

Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial

PLoS ONE2017-01-1862 citations

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

2006-03-01537 citations